Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2068 of 6351
-
New drug duo shows promise in shrinking tough cancers
Disease control CompletedThis study has 2 parts. The first part was open to adults with advanced non-small cell lung cancer. The second part was open also to adults with other types of advanced cancer of the lung, brain, skin, and liver. After early encouraging results, more people with liver cancer can …
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug targets rare gene mutations in Hard-to-Treat cancers
Disease control OngoingThis phase II MATCH treatment trial tests how well erdafitinib (JNJ-42756493) works in treating patients with tumors that have FGFR mutations or fusions. Erdafitinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal FGFR protein…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
A web program may ease the emotional toll of chemotherapy hair loss
Symptom relief CompletedThis randomized controlled trial evaluated the effects of a web-based alopecia education program on body image, self-esteem, chemotherapy-induced alopecia-related quality of life, and psychological well-being among women with breast cancer receiving chemotherapy. A total of 68 wo…
Sponsor: Gulay Akman • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New combo approach for Lung-Limited colorectal cancer shows promise in early trial
Disease control OngoingThis phase II trial studies how well chemotherapy and/or metastasectomy work in treating patients with colorectal adenocarcinoma that has spread to the lungs (metastases). Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the c…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could one HPV shot be enough? 20-Year study seeks answers
Knowledge-focused OngoingThis study is extending follow up of women who participated in the Costa Rica Vaccine Trial (CVT) and received one dose or two doses of the human papillomavirus (HPV) vaccine, along with a group of women who received three doses. It also studies the stability of HPV defenses in t…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
New fetal heart monitor could unlock secrets of stillbirth
Knowledge-focused Recruiting nowEach year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common than Sudden Infant Death Syndrome. This study will apply a novel type of non-invasive monitoring, called fetal magnetoc…
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New wireless monitor aims to prevent dangerous low blood sugar in hospitalized veterans
Disease control OngoingMore than 25% of the patients admitted in the general wards have a history of Diabetes Mellitus (DM). Up to 30% of the hospitalized diabetics develop hypoglycemia (low glucose values); a condition that is associated with seizures, cardiac arrhythmias, and even death. In Veterans,…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can mindfulness break the cycle of alcohol abuse and incarceration?
Disease control CompletedOver half of state and federal prisoners meet clinical criteria for alcohol abuse or dependence, and after release from prison, over three-quarters of offenders are re-arrested within five years. Thus, there is a critical need for more effective interventions that could help disr…
Sponsor: The Mind Research Network • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a steroid and exercise beat cancer fatigue?
Symptom relief OngoingThis phase II/III trial studies how well physical activity with or without dexamethasone works in reducing cancer-related fatigue in patients with cancer that has spread to other places in the body or has come back. Dexamethasone may decrease the body's immune response. Combining…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Nose drop vaccines aim to protect kids from RSV
Vaccine CompletedThe purpose of this study is to evaluate the infectivity, safety, and immunogenicity of a single dose of recombinant, live-attenuated respiratory syncytial virus (RSV) vaccines (RSV 6120/∆NS1 or RSV 6120/F1/G2/∆NS1) in RSV-seropositive children 12 to 59 months of age and RSV-sero…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 09:05 UTC
-
Simple blood or urine test could spot kidney cancer early
Diagnosis CompletedThis study is being done to collect blood, tissue and urine samples to identify a novel high quality methylated DNA marker in patients with renal tumors.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Could a common drug shrink rare growths in Kids' faces and necks?
Disease control Recruiting nowTo evaluate the efficacy of Rapamycin in extended cervicofacial lymphatic malformations in pediatric patients. Rapamycin is administered oral for a 6 month period. The success rate is determined by volume reduction superior to 1/5e of the initial volume measured by MRI, impact o…
Phase 2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New study tracks Nucala's Long-Term impact on rare inflammatory disease
Disease control CompletedThis study is a drug use investigation program of NUCALA. The objective of this study is to collect and assess information on the safety and effectiveness of the long-term use of NUCALA SC injection in daily clinical practice in subjects with Eosinophilic Granulomatosis with Poly…
Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New balloon could ease urinary blockages without surgery
Disease control OngoingROBUST III is a prospective, multi-center, randomized controlled adaptive sample size clinical trial to establish the safety and effectiveness for the Optilume Stricture Drug Coated Balloon (DCB).
Sponsor: Urotronic Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New Nurse-Led programs aim to keep women with HIV healthy in durban
Disease control CompletedThe Siyaphambili Study is a sequential multistage adaptive randomized trial (SMART) to compare the effectiveness and durability of two behavioral interventions on the HIV-1 virologic response among female sex workers (FSW) living with HIV in Durban, South Africa. The intervention…
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Mobile van brings HIV prevention and treatment directly to drug users
Disease control CompletedThere are several biomedical interventions that can help people who inject drugs (particularly those with or at risk for HIV), but these services often do not get to the people most in need. In this project investigators propose to determine if delivery of these services to PWID …
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can doubling the dose stop prostate cancer from worsening?
Disease control CompletedThe purpose of this study is to test whether a dose escalation up to 2000 mg per day of abiraterone acetate is feasible and lead to disease stabilization in castration-resistant metastatic prostate cancer patients who experience disease progression within the first 6 months of ab…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 14:08 UTC
-
Asthma drug dupilumab tested for Long-Term safety in kids
Disease control CompletedPrimary Objective: * To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a previous dupilumab asthma clinical study. * To evaluate the efficacy of dupilumab in children of 6 to \<12 years of age with uncontrolled p…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Laser precision could halt keratoconus progression and sharpen vision
Disease control Recruiting nowOptical Coherence Tomography (OCT) devices are non-contact instruments that can measure the depth of scars, other causes of cloudiness of the cornea, and degree of corneal thinning in patients with keratoconus. Laser Custom Corneal Collagen Cross-linking (CXL) significantly decre…
Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 26, 2026 15:19 UTC
-
Cancer-Killing virus plus immunotherapy shows promise in kidney cancer trial
Disease control CompletedThis is a Phase 1b/2a, open-label, multi-center, dose-escalation and safety/efficacy evaluation trial of Pexa-Vec plus Cemiplimab in patients with metastatic or unresectable renal cell carcinoma (RCC). The trial consists of a dose-escalation stage, where the maximum feasible dose…
Phase 1/2 • Sponsor: SillaJen, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC